13:39 EDT Can-Fite BioPharma (CANF) trading halted, news pending
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CANF:
- Can-Fite Projects $685M Revenue from Partnerships
- Can-Fite BioPharma announces completion of analysis of current partnerships
- Can-Fite BioPharma Reports 2024 Financial Results and Clinical Advances
- Can-Fite BioPharma reports FY24 EPS 0c vs 1c last year
- Can-Fite BioPharma initiates Phase 3 psoriasis study of piclidenoson